Showing 1071-1080 of 6036 results for "".
How to Recognize Glaucoma From Its Common Masqueraders
https://modernod.com/topics/glaucoma/how-to-recognize-glaucoma-from-its-common-masqueraders/38653/Helpful pearls for making the distinction.70. Case Reflection - Breaking Up with a Patient
https://modernod.com/podcasts/four-eyes/70-case-reflection-breaking-up-with-a-patient/37020/Four Eyes is sharing an all-new Case Reflection episode where Dr. Bilkhu and Dr. Kar discuss a patient encounter that led to firing the patient from the practice. This is an important conversation that new graduates and young ODs can learn from, especially when working as an associate doctor withinThe Era of Retina Disease Treatment Options?
https://modernod.com/articles/significant-findings/the-era-of-retina-disease-treatment-options/37739/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPotential Treatment Found for Age and Diabetes-Induced Eye Disease
https://modernod.com/articles/significant-findings/potential-treatment-found-for-age-and-diabetes-induced-eye-disease/37735/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatEyenovia Celebrates First FDA Approval
https://modernod.com/articles/significant-findings/eyenovia-celebrates-first-fda-approval/37736/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDry Eye Market Heating Up
https://modernod.com/articles/significant-findings/dry-eye-market-heating-up/37737/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDrug Shortages Due to Dual Indications
https://modernod.com/articles/significant-findings/drug-shortages-due-to-dual-indications/37738/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatFDA Flags Improperly Marketed Amniotic Fluid Eye Drops
https://modernod.com/articles/significant-findings/fda-flags-improperly-marketed-amniotic-fluid-eye-drops/37734/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatNew TFOS Workshop Report Available
https://modernod.com/articles/significant-findings/new-tfos-workshop-report-available/37733/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatCome One, Come All to the ICSC!
https://modernod.com/mod-issues/2023-apr/come-one-come-all-to-the-icsc/38606/